MedPath

A Validation Study of Mobile Virtual Reality-Based Self-Care and Exposure Therapy Contents for the Treatment of Panic Disorder

Not Applicable
Completed
Conditions
Panic Disorder
Interventions
Procedure: Arm I (Prepectoral)
Other: Arm II (Subpectoral)
Registration Number
NCT04985019
Lead Sponsor
Gangnam Severance Hospital
Brief Summary

The purpose of this study is to determine whether mobile-based virtual reality exposure treatement can reduce the symptoms of panic disorder and the symptoms of depression and anxiety than the waitlist group

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Meet Diagnostic Statistical Manual criteria for panic disorder(with or without agoraphobia) .

No change in drug dosage during the study period

Exclusion Criteria
  • Patients with a history of major neurological or significant medical illness, or met the diagnostic criteria of current substance misuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
I (Prepectoral)Arm II (Subpectoral)VR treatment group Participants received the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for panic disorder.
I (Prepectoral)Arm I (Prepectoral)VR treatment group Participants received the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for panic disorder.
Primary Outcome Measures
NameTimeMethod
The Panic Disorder Severity Scale4 weeks

The Panic Disorder Severity Scale consists of 7 items, each rated on a 5-point scale that assesses panic frequency, distress during panic, panic-focused anticipatory anxiety, phobic avoidance of situations, phobic avoidance of physical sensations, impairment in work functioning, and impairment in social functioning

Secondary Outcome Measures
NameTimeMethod
The Korean Inventory of Depressive Symptomatology4 weeks

The Korean Inventory of Depressive Symptomatology is a self-report questionnaire that comprises symptoms of depression including melancholic, atypical and anxious symptoms

The Albany Panic and Phobia Questionnaire4 weeks

The Albany Panic and Phobia Questionnaire is a 27-item 9-point Likert scale that was designed to measure the distinct dimension of fear in various situations, and has three subscales: social phobia, agoraphobia, and interoceptive fear

The heart rate variability4 weeks

The heart rate variability is the physiological recordings of the variation in the time interval between consecutive heartbeats in milliseconds

The Perceived Stress Scale4 weeks

The Perceived Stress Scale is is a measure of the degree to which situations in one's life are appraised as stressful

The Hospital Anxiety and Depression Scale4 weeks

The Hospital Anxiety and Depression Scale is a 14-item scale that has anxiety and depression subscales;

The Body Sensations Questionnaire4 weeks

The Body Sensations Questionnaire is a 17-item 5-point Likert scale that evaluates how afraid and anxious a patient is when he/she feels the physical sensation of each item in an unstable state

The Hamilton Rating Scale for Depression4 weeks

The Hamilton Rating Scale for Depression is a depression assessment scale and contains 17 items pertaining to symptoms of depression experienced over the past week

The State and Trait Anxiety questionnaire4 weeks

The State and Trait Anxiety questionnaire is has 20 items for assessing trait anxiety and 20 for state anxiety

The Anxiety Sensitivity Index4 weeks

The Anxiety Sensitivity Index is a 16-item measure tapping the fear of anxiety sensations, which is known to be a risk factor for the development of panic.

Trial Locations

Locations (1)

Gangnam Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath